Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
International
●Clinical practice guideline for the prevention of oral and oropharyngeal mucositis in pediatric cancer and hematopoietic stem cell transplant patients, update (2021)
●International Society of Oral Oncology (ISOO)/Multinational Association of Supportive Care in Cancer (MASCC)/American Society of Clinical Oncology (ASCO): Guideline on salivary gland hypofunction and/or xerostomia induced by nonsurgical cancer therapies (2021)
●MASCC/ISOO: Clinical practice guidelines for the management of mucositis secondary to cancer therapy (2020)
●MASCC/ISOO: Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients and clinical practice guidelines (2020)
●MASCC/ISOO: Systematic review of growth factors and cytokines for the management of oral mucositis in cancer patients and clinical practice guidelines (2020)
●MASCC/ISOO: Systematic review of natural and miscellaneous agents, for the management of oral mucositis in cancer patients and clinical practice guidelines – Part 2: Honey, herbal compounds, saliva stimulants, probiotics, and miscellaneous agents (2020)
●MASCC/ISOO: Systematic review of oral cryotherapy for the management of oral mucositis in cancer patients and clinical practice guidelines (2020)
●MASCC/ISOO: Systematic review of agents for the management of cancer treatment-related gastrointestinal mucositis and clinical practice guidelines (2019)
●MASCC/ISOO: Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients and clinical practice guidelines (2019)
●MASCC/ISOO: Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines (2019)
●MASCC/ISOO: Systematic review of natural and miscellaneous agents for the management of oral mucositis in cancer patients and clinical practice guidelines – Part 1: Vitamins, minerals, and nutritional supplements (2019)
●MASCC/ISOO: Systematic review of photobiomodulation for the management of oral mucositis in cancer patients and clinical practice guidelines (2019)
Canada
●Cancer Care Ontario (CCO): Symptom management algorithm – Oral mucositis in adults with cancer
United States
●Oncology Nursing Society (ONS): Symptom interventions and guidelines on mucositis
●Children's Oncology Group (COG): Guideline for the prevention of oral and oropharyngeal mucositis (2022)
●International Society of Oral Oncology (ISOO)/Multinational Association of Supportive Care in Cancer (MASCC)/American Society of Clinical Oncology (ASCO): Guideline on salivary gland hypofunction and/or xerostomia induced by nonsurgical cancer therapies (2021)
Europe
●European Society for Medical Oncology (ESMO): Management of oral and gastrointestinal mucosal injury – Clinical practice guidelines for diagnosis, treatment, and follow-up (2015)
United Kingdom
●National Institute for Health and Care Excellence (NICE): Interventional procedures guidance on low-level laser therapy for preventing or treating oral mucositis caused by radiotherapy or chemotherapy (2018)
